APELLIS PHARMACTDL (Germany) Buy Hold or Sell Recommendation
| 1JK Stock | EUR 31.28 0.82 2.55% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding APELLIS PHARMACTDL 0001 is 'Strong Sell'. Macroaxis provides APELLIS PHARMACTDL buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 1JK positions.
Check out APELLIS PHARMACTDL Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as APELLIS and provide practical buy, sell, or hold advice based on investors' constraints. APELLIS PHARMACTDL 0001. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
APELLIS |
Execute APELLIS PHARMACTDL Buy or Sell Advice
The APELLIS recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on APELLIS PHARMACTDL 0001. Macroaxis does not own or have any residual interests in APELLIS PHARMACTDL 0001 or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute APELLIS PHARMACTDL's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
APELLIS PHARMACTDL Trading Alerts and Improvement Suggestions
| APELLIS PHARMACTDL had very high historical volatility over the last 90 days | |
| The company reported the revenue of 113.05 M. Net Loss for the year was (460.28 M) with loss before overhead, payroll, taxes, and interest of (253.92 M). | |
| APELLIS PHARMACTDL 0001 has accumulated about 599.01 M in cash with (239.85 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.89. | |
| Over 89.0% of the company shares are owned by institutions such as pension funds |
APELLIS PHARMACTDL Returns Distribution Density
The distribution of APELLIS PHARMACTDL's historical returns is an attempt to chart the uncertainty of APELLIS PHARMACTDL's future price movements. The chart of the probability distribution of APELLIS PHARMACTDL daily returns describes the distribution of returns around its average expected value. We use APELLIS PHARMACTDL 0001 price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of APELLIS PHARMACTDL returns is essential to provide solid investment advice for APELLIS PHARMACTDL.
| Mean Return | 0.06 | Value At Risk | -5.08 | Potential Upside | 7.84 | Standard Deviation | 4.26 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of APELLIS PHARMACTDL historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
APELLIS PHARMACTDL Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to APELLIS PHARMACTDL or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that APELLIS PHARMACTDL's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a APELLIS stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.04 | |
β | Beta against Dow Jones | 0.19 | |
σ | Overall volatility | 4.05 | |
Ir | Information ratio | 0.01 |
APELLIS PHARMACTDL Volatility Alert
APELLIS PHARMACTDL 0001 shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure APELLIS PHARMACTDL's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact APELLIS PHARMACTDL's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.APELLIS PHARMACTDL Fundamentals Vs Peers
Comparing APELLIS PHARMACTDL's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze APELLIS PHARMACTDL's direct or indirect competition across all of the common fundamentals between APELLIS PHARMACTDL and the related equities. This way, we can detect undervalued stocks with similar characteristics as APELLIS PHARMACTDL or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of APELLIS PHARMACTDL's fundamental indicators could also be used in its relative valuation, which is a method of valuing APELLIS PHARMACTDL by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare APELLIS PHARMACTDL to competition |
| Fundamentals | APELLIS PHARMACTDL | Peer Average |
| Return On Equity | -5.07 | -0.31 |
| Return On Asset | -0.46 | -0.14 |
| Operating Margin | (4.60) % | (5.51) % |
| Shares Outstanding | 110.58 M | 571.82 M |
| Shares Owned By Insiders | 15.32 % | 10.09 % |
| Shares Owned By Institutions | 89.16 % | 39.21 % |
| Revenue | 113.05 M | 9.43 B |
| Gross Profit | (253.92 M) | 27.38 B |
| EBITDA | (518.43 M) | 3.9 B |
| Net Income | (460.28 M) | 570.98 M |
| Cash And Equivalents | 599.01 M | 2.7 B |
| Cash Per Share | 6.89 X | 5.01 X |
| Total Debt | 409.63 M | 5.32 B |
| Debt To Equity | 7.94 % | 48.70 % |
| Current Ratio | 4.15 X | 2.16 X |
| Book Value Per Share | 2.78 X | 1.93 K |
| Cash Flow From Operations | (239.85 M) | 971.22 M |
| Earnings Per Share | (7.48) X | 3.12 X |
| Target Price | 67.81 | |
| Number Of Employees | 767 | 18.84 K |
| Beta | 1.23 | -0.15 |
| Market Capitalization | 5.78 B | 19.03 B |
| Z Score | 8.4 | 8.72 |
APELLIS PHARMACTDL Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as APELLIS . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 31.28 | |||
| Day Typical Price | 31.28 | |||
| Price Action Indicator | (0.41) | |||
| Period Momentum Indicator | (0.82) |
About APELLIS PHARMACTDL Buy or Sell Advice
When is the right time to buy or sell APELLIS PHARMACTDL 0001? Buying financial instruments such as APELLIS Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having APELLIS PHARMACTDL in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Utilities ETFs Thematic Idea Now
Utilities ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Utilities ETFs theme has 13 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Utilities ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in APELLIS Stock
APELLIS PHARMACTDL financial ratios help investors to determine whether APELLIS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in APELLIS with respect to the benefits of owning APELLIS PHARMACTDL security.